Founder and Advisor in InnoCentive
Alph Bingham, Ph.D. is a member of the Board and co-founder of InnoCentive, Inc. He has been a strong advocate of open innovation and founded InnoCentive along with other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc. Dr. Bingham currently serves on the Board of Directors of Fast Track Systems, Inc., and Collaborative Drug Discovery, Inc.; the advisory boards of the Center for Collective Intelligence (MIT), Phase Forward, Inc., YourEncore, Inc. and Coalesix, Inc. He has lectured extensively at both national and international events and serves as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. Dr. Bingham is also the former chairman of the Board of Editors of the Research Technology Management Journal. He was the recipient of the Economist's Fourth Annual Innovation Summit "Business Process Award" for InnoCentive. He was also named as one of Project Management Institute's "Power 50" leaders in October 2005. Dr. Bingham had over 25 years of experience with Eli Lilly and Company in pharmaceutical research and development, research acquisitions and collaborations, portfolio management and R&D strategic planning. Among others, he held positions as Managing Director of the Mont-Saint-Guibert Development Centre, executive director of project and portfolio management, vice-president of sourcing innovation, vice-president of e.Lilly and vice-president of R&D strategy. During his career, he was instrumental in creating and developing Eli Lilly's portfolio management process as well as establishing the divisions of Research Acquisitions, the Office of Alliance Management and e.Lilly, a unit for business innovation. In April 2011, Dr. Bingham co-authored with Dwayne Spradlin the groundbreaking book, The Open Innovation Marketplace, published by FT Press. He received a B.S. in chemistry from Brigham Young University and a Ph.D. in organic chemistry from Stanford University.